Managing Tardive Dyskinesia: Risk Factors, Early Detection, and Effective Treatments
Patients with conditions such as schizophrenia, bipolar disorder, and major [...]
| Categories: tardive-dyskinesia
Patients with conditions such as schizophrenia, bipolar disorder, and major depressive disorder are at high risk for developing tardive dyskinesia (TD). Read More> https://tardivedyskinesia.pocn.com/diagnosis/managing-tardive-dyskinesia-risk-factors-early-detection-and-effective-treatments/
Patients with conditions such as schizophrenia, bipolar disorder, and major [...]
Tardive dyskinesia (TD) is typically caused by long-term use of [...]
Tardive dyskinesia (TD) is most commonly linked to long-term use [...]
This study examines the impact of tardive dyskinesia (TD) on [...]
Researchers of a study aimed to evaluate the broad impact [...]
In a discussion led by Rakesh Jain, MD, MPH, experts [...]
Tardive dyskinesia (TD) is an involuntary movement disorder that develops [...]
Tardive dyskinesia (TD) is a movement disorder caused by prolonged [...]
This complex case features an intellectually challenged 53-year-old male who [...]
Stable on multiple medications, a patient had been treated for [...]
Due to long-term use of antipsychotic medications, oral tardive dyskinesia [...]
A patient works full-time as an auditor and has three [...]
Tardive dyskinesia (TD) syndromes involve abnormal involuntary movements, ranging from [...]
A consensus panel of nine experts developed the Impact-TD scale [...]
The development of tardive dyskinesia (TD) is influenced by various [...]
Benztropine, an anticholinergic medication, is prescribed short-term for drug-induced movement [...]
To minimize the symptoms of tardive dyskinesia (TD), stress reduction [...]
This case study examines the case of a 54-year-old male [...]
This brief video explores tardive dyskinesia (TD) and its [...]
Tardive dyskinesia (TD) is a movement disorder causing involuntary movements [...]
Tardive dyskinesia (TD) presents challenges beyond its visible symptoms, impacting [...]
Researchers investigated the role of neuronal degeneration in tardive dyskinesia [...]
Researchers of a study highlighted the effectiveness of an annual [...]
Researchers of this study evaluated the bioequivalence of once-daily and [...]
Authors of an article summarized information on cannabidiol (CBD), a [...]
In a recent study, researchers aimed to develop and evaluate [...]
Researchers of the RE-KINECT study (NCT03062033), aimed to understand the [...]
Researchers of a recent study focused on developing and validating [...]
Researchers of a study investigated how tardive dyskinesia (TD) impacts [...]
An expert advisory panel has developed consensus recommendations for assessing [...]
The “Dyskinesia Pipeline Insight 2023” report from DelveInsight offers an [...]
Shedding Light on Tardive Dyskinesia: A Video Discussion With Michael [...]
A study shows the increased risk of tardive dyskinesia [...]
In a study, researchers reviewed the symptoms, causes, and [...]
Researchers of a study looked at the current knowledge [...]
Researchers of a study analyzed comorbidities and outcomes in [...]
Researchers of a study looked into psychostimulants, a group of [...]
In a recent study, researchers aimed to understand the effects [...]
Researchers of a recent study aimed to understand the impact [...]
In an announcement, Teva Pharmaceuticals released the IMPACT-TD Scale, a [...]
Researchers in a recent study gathered information on tardive syndrome [...]
This article identifies six key points that people with [...]
Researchers of a study examined the impact of tardive dyskinesia [...]
A recent study analyzed the minimal clinically important change (MCIC) [...]
Researchers of a recent study examined tardive dyskinesia (TD) and [...]
A recent study analyzed the early warning signs and symptoms [...]
In a recent study, researchers aimed to understand why tardive [...]
Researchers of a study explored the pathophysiology of extrapyramidal effects [...]